Geode Capital Management’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,901
Closed -$38.4K 4551
2024
Q2
$38.4K Hold
5,901
﹤0.01% 4333
2024
Q1
$43.7K Hold
5,901
﹤0.01% 4346
2023
Q4
$49.5K Hold
5,901
﹤0.01% 4352
2023
Q3
$34.6K Hold
5,901
﹤0.01% 4518
2023
Q2
$63.1K Hold
5,901
﹤0.01% 4455
2023
Q1
$37.2K Hold
5,901
﹤0.01% 4585
2022
Q4
$41K Hold
5,901
﹤0.01% 4644
2022
Q3
$48K Hold
5,901
﹤0.01% 4773
2022
Q2
$45K Hold
5,901
﹤0.01% 4797
2022
Q1
$76K Hold
5,901
﹤0.01% 4727
2021
Q4
$96K Hold
5,901
﹤0.01% 4746
2021
Q3
$155K Buy
5,901
+3,228
+121% +$94.2K ﹤0.01% 4540
2021
Q2
$91K Buy
2,673
+776
+41% +$30.4K ﹤0.01% 4580
2021
Q1
$95K Hold
1,897
﹤0.01% 4314
2020
Q4
$89K Buy
+1,897
New +$66.9K ﹤0.01% 4072

Other funds holding EVGN

Geode Capital Management's EVGN Position: Q3 2024 in Review

Geode Capital Management sold out of Evogene (EVGN) in Q3 2024, closing a stake of 5,901 shares — an estimated $38.4K sold.

Geode Capital Management first reported a position in EVGN in Q4 2020 and held it in 15 quarters. The position peaked at $155K in Q3 2021. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

  • Geode Capital Management reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
  • Geode Capital Management sold 5,901 Evogene shares in Q3 2024, an estimated $38.4K.
  • Geode Capital Management first reported a position in Evogene in Q4 2020 and held it in 15 quarters.
  • Geode Capital Management's Evogene position peaked at $155K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.